Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) saw a large decline in short interest in October. As of October 30th, there was short interest totaling 7,541 shares, a decline of 84.7% from the October 15th total of 49,143 shares. Based on an average daily trading volume, of 342,511 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Jin Medical International in a report on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Jin Medical International currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on ZJYL
Jin Medical International Stock Performance
Shares of Jin Medical International stock opened at $4.21 on Wednesday. The business has a fifty day simple moving average of $2.21 and a 200-day simple moving average of $2.37. Jin Medical International has a fifty-two week low of $1.53 and a fifty-two week high of $5.68. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.70 and a current ratio of 1.95.
About Jin Medical International
Jin Medical International Limited is a medical device company focused on the design, manufacture and sale of mobility and daily-living assistance products. Through its operating subsidiaries in China, the company serves customers seeking equipment intended to support mobility, personal care and home or institutional use. The company’s product portfolio includes manual wheelchairs, electric wheelchairs, walking aids and other related medical and rehabilitation equipment. Its offerings are marketed through domestic and international sales channels, serving distributors, retailers and other customers in China and overseas markets.
Featured Stories
- Five stocks we like better than Jin Medical International
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.
